20/05/2026 Savara presented biomarker data from the Phase 3 trial of molgramostim inhalation solution in aPAP at the ATS International Conference 2026 Savara presented biomarker data from the Phase 3 trial of molgramostim inhalation solution in aPAP at the ATS International Conference 2026 (Ref) Savara presented a poster at American Thoracic Society (ATS) International Conference 2026. The poster reported new biomarker data from the Phase 3, IMPALA-2, double blind study which

19/05/2026 UCB announced week 16 data from the BE BOLD study in PsA Zenas BioPharma announced the upcoming presentation of results from the Phase 3 trial of Obexelimab in IgG4-RD at EULAR 2026 Congress Savara presented long-term data from the Phase 3 OLE study of molgramostim inhalation solution in aPAP Tiziana announced positive data for intranasal foralumab in non-active secondary progressive multiple sclerosis ImmuneOnco announced first patient dosed in Phase 2 trial of mo